Oxford, United Kingdom

Miguel Varela

This inventor holds 3 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignees: Oxford University Innovation Ltd, United Kingdom Research and Innovation. Active years: 2025-2026.

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Miguel Varela: Innovator in Cell-Penetrating Peptides

Introduction

Miguel Varela is a notable inventor based in Oxford, GB. He has made significant contributions to the field of biotechnology, particularly through his work on cell-penetrating peptides. His innovative approach has the potential to impact the treatment of various genetic disorders.

Latest Patents

Miguel Varela holds a patent related to cell-penetrating peptides. The present invention pertains to peptides, specifically cell-penetrating peptides, and their conjugates with therapeutic molecules. This invention is particularly relevant in the treatment of genetic disorders, including muscular dystrophies such as Duchenne muscular dystrophy.

Career Highlights

Throughout his career, Miguel has worked with prominent organizations, including Oxford University Innovation Limited and United Kingdom Research and Innovation. His work has been instrumental in advancing research and development in the field of therapeutic peptides.

Collaborations

Miguel has collaborated with notable colleagues, including Matthew Wood and Raquel Manzano. These partnerships have further enriched his research and contributed to the success of his innovations.

Conclusion

Miguel Varela's work in cell-penetrating peptides showcases his dedication to advancing medical science. His contributions have the potential to lead to significant breakthroughs in the treatment of genetic disorders.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…